Gram-Positive vs Gram-Negative Cell Walls: A Comparative Guide

Gram staining remains the first diagnostic step in most clinical microbiology laboratories, yet the relationship between stain color and cell wall architecture is more complex than the classic purple versus pink dichotomy suggests. This guide compares the structural organization of Gram-positive and Gram-negative cell envelopes, explains the staining mechanism, and translates those differences into practical decisions for laboratory workflow, antimicrobial susceptibility testing, and biosafety handling. The content is written for laboratory students, technicians, researchers, and diagnostic professionals who need a working understanding of cell wall biology instead of a purely theoretical treatment.

At a Glance

The table below summarizes the key structural and functional differences between Gram-positive and Gram-negative cell walls. These distinctions drive decisions about staining interpretation, antibiotic selection, disinfection protocols, and diagnostic test design.

The practical implication is straightforward. A purple result tells you the organism has a thick peptidoglycan layer accessible to the stain. A pink result tells you the organism has an outer membrane that prevents crystal violet retention. Neither result alone tells you the full resistance profile or the exact phylogenetic position of the organism.

Cell Wall Architecture and the Gram Reaction

The Gram stain procedure relies on the differential retention of crystal violet after decolorization with alcohol or acetone. The mechanism has been studied for decades, and the current understanding links stain retention to the physical and chemical properties of the cell envelope instead of to a simple thickness measurement alone. Early work on the staining mechanism examined how crystal violet interacts with bacterial cells and why some cells resist decolorization while others do not. The relationship between the staining mechanism and the structural organization of the cell wall was established through comparative studies of staining behavior across diverse bacterial groups.

The classic model holds that the thick peptidoglycan layer of Gram-positive cells traps the crystal violet iodine complex after decolorization, while the thin peptidoglycan layer of Gram-negative cells cannot retain the complex. The outer membrane of Gram-negative cells is dissolved by the decolorizer, which also extracts lipid components and allows the crystal violet to wash out. The counterstain, typically safranin or carbol fuchsin, then colors the now colorless Gram-negative cells pink or red.

Modern research has complicated this picture. A 2026 study examining Bacillaceae lineages historically classified as Gram-positive found that some strains stain pink despite lacking an outer membrane and retaining thick peptidoglycan walls. These organisms, termed Gram-negative-staining monoderms, lack lipopolysaccharide and beta-barrel assembly genes yet remain susceptible to vancomycin and lysozyme, agents that are normally excluded by the outer membrane of true diderm bacteria. The study concluded that teichoic acid biosynthetic pathways are patchily distributed across these lineages and do not predict staining behavior. This finding challenges the textbook assumption that stain color reliably indicates membrane architecture.

For the diagnostic laboratory, the practical lesson is that Gram stain morphology should be interpreted alongside other evidence. A pink-staining rod that is otherwise consistent with a Bacillus species should not be automatically assigned to a Gram-negative genus. Genome-based identification may be necessary for accurate classification, particularly for emerging pathogens in groups where staining behavior is unreliable.

Peptidoglycan Structure and Biosynthesis

Peptidoglycan is the load-bearing component of the bacterial cell wall and is essential for maintaining cellular integrity and morphology. The molecule consists of glycan chains of alternating N-acetylglucosamine and N-acetylmuramic acid residues, cross-linked by short peptide stems. The degree of cross-linking and the thickness of the peptidoglycan layer differ substantially between Gram-positive and Gram-negative organisms.

Gram-positive cell walls typically contain many layers of peptidoglycan, often 20 to 80 nanometers thick, with extensive cross-linking that provides mechanical strength. Gram-negative cell walls contain a much thinner peptidoglycan layer, often only one to three nanometers thick, located in the periplasmic space between the inner and outer membranes. The thin peptidoglycan layer of Gram-negative bacteria is sufficient for structural integrity because the outer membrane provides an additional permeability barrier and mechanical support.

The biosynthesis of peptidoglycan is a highly regulated process involving coordinated control of synthetic and hydrolytic pathways. A 2026 review described the multilayered regulatory networks that govern peptidoglycan dynamics, including transcriptional regulators, two-component systems, non-coding small RNAs, scaffold proteins, and protein-protein interactions. These regulatory mechanisms allow bacteria to remodel their cell walls during growth, division, and environmental stress. The same review noted that understanding these regulatory processes reveals promising targets for antimicrobial drug development, since disrupting peptidoglycan synthesis or turnover can be lethal to bacteria.

Penicillin-binding proteins are the enzymes that catalyze the cross-linking of peptidoglycan peptide stems. These proteins are the targets of beta-lactam antibiotics. A 2026 review focused on penicillin-binding protein 4 (PBP4) in Staphylococcus aureus described how mutations in this protein lead to altered expression and resistance to next-generation beta-lactams in both methicillin-susceptible and methicillin-resistant backgrounds. PBP4 is the sole low-molecular-mass penicillin-binding protein in S. aureus and the only known low-molecular-mass penicillin-binding protein with transpeptidase activity, giving it a unique role in peptidoglycan cross-linking. The review highlighted the increasing relevance of PBP4 as a mediator of beta-lactam resistance and discussed its potential as a target during infection diagnosis and therapy.

For laboratory professionals, the clinical relevance of peptidoglycan biology is direct. Susceptibility testing for beta-lactams and glycopeptides depends on the accessibility and function of the peptidoglycan synthesis machinery. Organisms with thickened cell walls may show reduced susceptibility to vancomycin even without classic resistance genes. A 2024 study of Enterococcus faecalis clinical isolates found that strains with decreased vancomycin susceptibility exhibited increased cell wall thickness compared with susceptible isolates of the same sequence type. Serial passage without vancomycin selection led to decreased cell wall thickness and decreased vancomycin minimum inhibitory concentrations, while serial passage with vancomycin selection caused increased cell wall thickness and increased minimum inhibitory concentrations. The study concluded that adaptive changes in cell wall thickness correlate with vancomycin susceptibility and emphasized the importance of monitoring these adaptive changes in clinical isolates.

The Outer Membrane of Gram-Negative Bacteria

The outer membrane is the defining feature of the Gram-negative cell envelope. This asymmetric lipid bilayer contains lipopolysaccharide in its outer leaflet and phospholipids in its inner leaflet. The lipopolysaccharide molecules extend into the surrounding environment and contribute to the permeability barrier that excludes many antibiotics, detergents, and host defense molecules.

Porin proteins embedded in the outer membrane form water-filled channels that allow the passive diffusion of small hydrophilic molecules, including nutrients and some antibiotics. The size exclusion limit of porins varies among species and determines which compounds can cross the outer membrane. Hydrophobic compounds and large molecules are generally excluded, which explains why many Gram-positive-active antibiotics are ineffective against Gram-negative bacteria.

The outer membrane also lacks the electron transport chain and ATP synthase found in the cytoplasmic membrane. Instead, it serves primarily as a permeability barrier and a scaffold for surface structures such as adhesins, secretion systems, and receptors for bacteriophages and bacteriocins.

The presence of the outer membrane has practical consequences for disinfection and antimicrobial treatment. A 2026 study of traditional and innovative sanitizers tested minimum bactericidal concentrations of 10 active ingredients against 11 bacterial species, including Gram-positive Staphylococcus aureus and Gram-negative Pseudomonas aeruginosa. The study found that Pseudomonas aeruginosa was resistant to 70 percent of the active ingredients tested, while resistance to 50 percent of the active ingredients was observed across the five strains examined. Peracetic acid, chlorhexidine digluconate, and neem extract eliminated all strains within one minute in minimum bactericidal concentration testing. The study also found that exposure of methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa to the most promising compounds promoted distinct alterations in intra- and extracellular metabolism, which were modulated by the bacterial cell wall structure.

For laboratory professionals, the outer membrane explains why Gram-negative organisms often require different disinfectants, higher concentrations, or longer contact times than Gram-positive organisms. It also explains why Gram-negative bacteria are frequently more resistant to antibiotics that target peptidoglycan synthesis, since the outer membrane limits access to the peptidoglycan layer.

Staining Mechanism and Interpretation

The Gram stain procedure involves four steps: application of crystal violet, addition of iodine mordant, decolorization with alcohol or acetone, and counterstaining with safranin or carbol fuchsin. The crystal violet and iodine form a large complex within the cell. Decolorization removes this complex from cells with thin peptidoglycan layers or disrupted outer membranes. The counterstain then colors the decolorized cells.

The molecular mechanism of the Gram stain has been investigated since the 1950s. Early studies examined the relationship between the staining mechanism of crystal violet and the mechanism of the Gram stain itself. Subsequent work in 1970 explored the molecular basis of the staining reaction, and later studies in 1992 proposed theoretical considerations of the staining mechanism based on a new bacterial staining method. More recent work in 2021 used in situ plasmon-enhanced coherent anti-Stokes Raman scattering and two-photon excitation fluorescence to identify non-fluorescent bacteria after Gram staining, providing a label-free approach to confirm stain results.

The interpretation of Gram stain results requires attention to several variables. Smear thickness affects stain retention, since overly thick smears may retain crystal violet unevenly. Decolorization time is critical, since over-decolorization can cause Gram-positive cells to appear pink and under-decolorization can cause Gram-negative cells to appear purple. The age of the culture also matters, since older cultures of some Gram-positive organisms may lose their ability to retain crystal violet.

Quality control for Gram staining should include known Gram-positive and Gram-negative control organisms processed alongside clinical specimens. The controls verify that the reagents are working correctly and that the technique is being applied consistently. Results from the controls should be recorded in the laboratory quality log.

Antimicrobial Susceptibility and Cell Wall Structure

The structural differences between Gram-positive and Gram-negative cell walls translate directly into differences in antimicrobial susceptibility. Beta-lactam antibiotics target penicillin-binding proteins involved in peptidoglycan cross-linking. Glycopeptides such as vancomycin and teicoplanin bind to the D-alanyl-D-alanine termini of peptidoglycan precursors and block transpeptidation. Lipopeptides such as friulimicin interfere with cell wall biosynthesis through calcium-dependent complexing of the bactoprenol phosphate carrier.

The outer membrane of Gram-negative bacteria excludes many of these agents. Vancomycin is generally ineffective against Gram-negative organisms because it cannot cross the outer membrane. Lysozyme, which hydrolyzes the glycan backbone of peptidoglycan, is similarly excluded. The 2026 study of Gram-negative-staining monoderms confirmed this functional distinction by showing that these organisms, despite staining pink, remain susceptible to vancomycin and lysozyme because they lack an outer membrane.

The relationship between cell wall structure and antimicrobial susceptibility is not static. Bacteria can adapt their cell wall thickness and composition in response to antibiotic exposure. The 2024 Enterococcus faecalis study demonstrated that cell wall thickness changes in response to vancomycin selection pressure, with increased thickness correlating with decreased susceptibility. This adaptive response can occur in clinical isolates that lack classic resistance genes, complicating susceptibility testing and treatment decisions.

For the diagnostic laboratory, the practical implication is that susceptibility testing should be performed on all clinically significant isolates instead of inferred solely from Gram stain morphology. The Gram stain provides a preliminary classification that guides initial antibiotic selection, but definitive therapy should be based on culture and susceptibility results.

Disinfection and Decontamination Considerations

The cell wall structure influences the efficacy of disinfectants and decontamination procedures. Gram-negative bacteria are often more resistant to disinfectants than Gram-positive bacteria due to the permeability barrier of the outer membrane. The 2026 sanitizer study found that Pseudomonas aeruginosa was resistant to 70 percent of the active ingredients tested, while resistance to 50 percent of the active ingredients was observed across the five strains examined. Peracetic acid, chlorhexidine digluconate, and neem extract eliminated all strains within one minute in minimum bactericidal concentration testing.

A 2019 study of bimetallic copper and zinc nanoparticles synthesized from Aspergillus iizukae secondary metabolites found that the nanoparticles were effective for inhibiting growth of Escherichia coli and Staphylococcus aureus in greywater. The maximum inactivation was optimized with 0.028 milligrams per milliliter of nanoparticles at pH 6 after 60 minutes, with reductions of 5.6 and 5.3 log for Escherichia coli and 5.2 and 5.4 log for Staphylococcus aureus for actual and predicted values, respectively. The inactivation mechanism involved damage to the cell wall structure, degradation of carbohydrates and amino structures on the bacterial cell wall, and destruction of carbon-carbon bonds in functional groups available in the cell wall.

A 2025 study of metal-ion zeolite materials tested antimicrobial activity against eight bacterial strains, including Escherichia coli, Enterococcus faecalis, Klebsiella pneumoniae, Staphylococcus saprophyticus, Proteus mirabilis, Pseudomonas aeruginosa, methicillin-sensitive Staphylococcus aureus, and methicillin-resistant Staphylococcus aureus. The study assessed bacterial susceptibility across differences in cell wall structure, growth phase, and strain type. The results showed that bacterial susceptibility varied across these factors, with cell wall structure being one of the contributing variables.

For laboratory professionals, the practical guidance is to select disinfectants based on the target organisms present in the laboratory environment. Surfaces that may be contaminated with Gram-negative organisms require disinfectants with proven activity against those organisms. The contact time and concentration specified by the disinfectant manufacturer should be followed exactly, since the efficacy of disinfectants depends on both factors.

Laboratory Workflow and Quality Control

The Gram stain is a rapid, inexpensive, and informative test that should be performed on all specimens submitted for bacterial culture. The workflow begins with specimen collection and transport, followed by smear preparation, staining, and microscopic examination. The results guide the selection of culture media and the initial choice of antimicrobial therapy.

Smear preparation requires attention to technique. A thin, even smear should be prepared from the specimen or from a single colony if the specimen is a pure culture. The smear should be air-dried and heat-fixed before staining. Heat fixation kills the bacteria and adheres them to the slide, but excessive heat can distort cell morphology and affect stain retention.

The staining procedure should be performed with quality-controlled reagents. The crystal violet, iodine, decolorizer, and counterstain should be replaced according to the manufacturer's recommendations or the laboratory's quality control schedule. Each new lot of reagents should be tested with known Gram-positive and Gram-negative control organisms before being used for clinical specimens.

Microscopic examination should be systematic. The smear should be scanned at low magnification to identify areas of optimal cell density, then examined at high magnification under oil immersion. The morphology, arrangement, and stain reaction of the organisms should be recorded. The presence of host cells, such as polymorphonuclear leukocytes, should also be noted, since this information is clinically relevant.

Quality control records should include the date, the control organisms used, the expected and observed results, and the initials of the technologist performing the test. Any discrepancy between expected and observed results should be investigated before patient specimens are reported.

Common Failure Patterns in Gram Staining

Several common errors can compromise Gram stain results. Over-decolorization is the most frequent problem, causing Gram-positive organisms to appear pink or red. This error is more likely when the decolorizer is applied for too long or when the smear is too thick. Under-decolorization causes Gram-negative organisms to appear purple, which can lead to misidentification and inappropriate antibiotic selection.

Old cultures are another source of error. Some Gram-positive organisms lose their ability to retain crystal violet as cultures age, particularly after 24 to 48 hours of incubation. This phenomenon is well documented for many species and can lead to false-negative Gram stain results. The laboratory should use fresh cultures for Gram staining whenever possible.

Smear thickness affects stain interpretation. Smears that are too thick may retain crystal violet unevenly, producing a mixture of purple and pink cells that is difficult to interpret. Smears that are too thin may contain too few organisms for reliable examination. The optimal smear should allow individual cells to be distinguished clearly.

Reagent contamination can also produce erroneous results. Gram-positive organisms in the counterstain or water can appear as purple cells in an otherwise pink smear. The laboratory should use filtered reagents and sterile water for staining procedures.

The 2026 study of Gram-negative-staining monoderms identified a more fundamental limitation of the Gram stain. Some organisms that are phylogenetically Gram-positive stain pink despite lacking an outer membrane. These organisms can be misidentified as Gram-negative if the stain result is interpreted without additional testing. The study recommended genome-guided diagnostics for accurate classification of such organisms, particularly for emerging pathogens such as Bacillus infantis.

Biosafety and Handling Considerations

The cell wall structure of bacteria influences their survival in the environment and their response to disinfectants, which has implications for laboratory biosafety. Gram-negative bacteria with outer membranes are generally more resistant to drying and to many disinfectants than Gram-positive bacteria. The outer membrane also protects against lysozyme and other host defense molecules, which may affect the survival of Gram-negative pathogens in the environment.

The World Health Organization Laboratory Biosafety Manual provides guidance on the safe handling of microorganisms in the laboratory. The manual covers risk assessment, containment levels, and safe work practices for handling potentially infectious materials. Laboratory professionals should consult the manual when establishing procedures for handling Gram-positive and Gram-negative pathogens.

The World Health Organization Laboratory Quality Management System Handbook provides guidance on quality assurance in the laboratory, including the use of quality control organisms, documentation of procedures, and verification of test results. The handbook emphasizes the importance of standardized procedures and quality control for reliable diagnostic testing.

For laboratory professionals, the biosafety implications of cell wall structure are practical. Gram-negative organisms that are resistant to disinfectants may require longer contact times or higher concentrations of disinfectants for effective decontamination. Spills of cultures containing Gram-negative organisms should be cleaned with a disinfectant with proven activity against the organism involved. Personal protective equipment, including gloves and laboratory coats, should be worn when handling bacterial cultures.

Detection and Identification Technologies

The cell wall provides a rich source of targets for bacterial detection and identification. Antibodies, whole phage particles, phage receptor binding proteins, cell wall-binding domains of peptidoglycan hydrolases, and functionalized magnetic nanoparticles can all bind to peptidoglycan and other cell wall components. A 2026 review described the development of detection kits based on these agents for rapid detection of pathogenic bacteria from genera including Acinetobacter, Bacillus, Campylobacter, Clostridium, Enterococcus, Klebsiella, Listeria, Pseudomonas, Salmonella, Shigella, Staphylococcus, Streptococcus, Vibrio, and Yersinia. The review noted that detection typically takes from a few minutes to a few hours, depending on the method.

These cell wall-targeting agents offer the potential to distinguish infectious pathogens from each other and from bacteria of the natural microbiota. They can also be used to detect bacteria directly in clinical specimens without prior culture, which is particularly valuable for slow-growing or fastidious organisms.

Phage endolysins are another class of cell wall-targeting agents with diagnostic and therapeutic potential. A 2026 review described the mechanisms of phage endolysins, their clinical progress, and emerging resistance frameworks. The review noted that phage endolysins have completed Phase II and III clinical trials and are increasingly recognized as alternatives to antibiotics for mitigating the growing threat of antimicrobial resistance.

For the diagnostic laboratory, cell wall-targeting detection methods offer several advantages over traditional culture-based methods. They are faster, can be performed directly on clinical specimens, and can distinguish between viable and non-viable cells in some cases. However, they require validation for each target organism and may not detect all strains within a species due to variation in cell wall composition.

Records and Documentation

Accurate records are essential for reliable Gram stain results and for quality assurance in the diagnostic laboratory. The laboratory should maintain records of reagent lot numbers, preparation dates, and expiration dates. Quality control results should be documented for each new lot of reagents and at regular intervals thereafter.

The World Health Organization Laboratory Quality Management System Handbook provides guidance on the documentation requirements for laboratory quality assurance. The handbook emphasizes the importance of standardized procedures, documented training, and regular audits to ensure the reliability of laboratory results.

For Gram staining, the laboratory should document the following information for each specimen: the date and time of specimen collection, the date and time of smear preparation, the staining procedure used, the results of quality control organisms, and the microscopic findings. The microscopic findings should include the stain reaction, morphology, and arrangement of organisms, as well as the presence of host cells.

The laboratory should also document any deviations from standard procedures, such as extended decolorization times or the use of alternative reagents. These deviations should be noted in the patient report if they may affect the interpretation of the results.

Professional Escalation Criteria

Laboratory professionals should escalate Gram stain results to the clinical team when the findings have immediate implications for patient management. The following situations warrant prompt communication:

A Gram stain result that is inconsistent with the clinical presentation should be communicated to the clinical team. For example, a Gram stain showing Gram-positive cocci in clusters from a blood culture is consistent with Staphylococcus aureus bacteremia and requires prompt antimicrobial therapy. A Gram stain showing mixed organisms from a normally sterile site may indicate contamination and should be interpreted with caution.

A Gram stain result that suggests a public health threat should be reported to the appropriate authorities. Organisms such as Bacillus anthracis, Francisella tularensis, and Yersinia pestis have characteristic Gram stain morphologies that may be recognized by experienced technologists. Any suspicion of a select agent should be reported immediately.

A Gram stain result that is technically questionable should be repeated before being reported. If the quality control organisms do not stain as expected, the patient results should not be reported until the problem is resolved. The laboratory should investigate the cause of the quality control failure and document the corrective action taken.

A Gram stain result that shows organisms with unusual morphology or staining characteristics should be referred to a senior technologist or clinical microbiologist for review. The 2026 study of Gram-negative-staining monoderms highlighted the risk of misidentifying pink-staining Bacillaceae as Gram-negative organisms. Genome-based identification may be necessary for accurate classification of such organisms.

Frequently Asked Questions

Why do Gram-positive bacteria stain purple while Gram-negative bacteria stain pink?

Gram-positive bacteria retain the crystal violet iodine complex after decolorization because their thick peptidoglycan layer traps the complex within the cell. Gram-negative bacteria lose the complex during decolorization because their thin peptidoglycan layer cannot retain it and the outer membrane is dissolved by the decolorizer. The counterstain then colors the decolorized Gram-negative cells pink or red.

Does Gram stain color always match cell wall architecture?

No. A 2026 study identified Gram-negative-staining monoderms in the Bacillaceae family that stain pink despite lacking an outer membrane and retaining thick peptidoglycan walls. These organisms remain susceptible to vancomycin and lysozyme, confirming their functional monoderm status. The study concluded that stain color does not always predict membrane architecture.

Why are Gram-negative bacteria often more resistant to antibiotics than Gram-positive bacteria?

The outer membrane of Gram-negative bacteria acts as a permeability barrier that excludes many antibiotics, including glycopeptides such as vancomycin. The outer membrane contains lipopolysaccharide in its outer leaflet and porin proteins that form channels for small hydrophilic molecules. Hydrophobic compounds and large molecules are generally excluded, which limits the entry of many antimicrobial agents.

Can bacteria change their cell wall thickness in response to antibiotics?

Yes. A 2024 study of Enterococcus faecalis found that strains exposed to vancomycin developed increased cell wall thickness, which correlated with decreased vancomycin susceptibility. Serial passage without vancomycin selection led to decreased cell wall thickness and increased susceptibility. These adaptive changes can occur in clinical isolates that lack classic resistance genes.

Why is the Gram stain not reliable for all bacteria?

The Gram stain can produce misleading results for several reasons. Over-decolorization can cause Gram-positive organisms to appear pink, while under-decolorization can cause Gram-negative organisms to appear purple. Old cultures of some Gram-positive organisms may lose their ability to retain crystal violet. Some organisms, such as the Gram-negative-staining monoderms identified in 2026, stain pink despite having Gram-positive cell wall architecture.

What quality control measures should be used for Gram staining?

Known Gram-positive and Gram-negative control organisms should be processed alongside clinical specimens with each new lot of reagents and at regular intervals thereafter. The expected and observed results should be recorded in the laboratory quality log. Any discrepancy should be investigated before patient specimens are reported.

How does cell wall structure affect disinfectant efficacy?

Gram-negative bacteria are often more resistant to disinfectants than Gram-positive bacteria due to the permeability barrier of the outer membrane. A 2026 study found that Pseudomonas aeruginosa was resistant to 70 percent of the active ingredients tested, while resistance to 50 percent of the active ingredients was observed across the five strains examined. Peracetic acid, chlorhexidine digluconate, and neem extract eliminated all strains within one minute in minimum bactericidal concentration testing.

When should genome-based identification be used instead of Gram stain morphology?

Genome-based identification should be used when the Gram stain result is inconsistent with other evidence, such as colony morphology, biochemical tests, or clinical presentation. The 2026 study of Gram-negative-staining monoderms recommended genome-guided diagnostics for accurate classification of pink-staining Bacillaceae, including emerging pathogens such as Bacillus infantis. Misidentifying these organisms as Gram-negative risks inappropriate therapy.

Related Diagnostic Guides

• DNA Extraction from Gram-Positive Bacteria: Overcoming the Cell Wall Barrier
• How to Set Up and Interpret Positive Controls in Gram Staining
• Polyacrylamide Gel Electrophoresis vs Agarose Gel Electrophoresis: Key Differences
• Negative Staining in Electron Microscopy: Principles and Controls
• Understanding Positive and Negative Controls in Microbiology Experiments

References and Further Reading

• Laboratory Quality Management System Handbook. World Health Organization.
• Laboratory Biosafety Manual. World Health Organization.
• Assay Guidance Manual. National Center for Advancing Translational Sciences.
• Bioanalytical Method Validation Guidance. U.S. Food and Drug Administration.
• NCBI Literature Resources. National Center for Biotechnology Information.
• 36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016.. Critical care (London, England), 2016.
• Traditional vs Innovative Sanitizers: In Vitro and In Situ Challenge in Multidrug-Resistant Bacteria.. ACS omega, 2026.
• Adaptive cell wall thickening in Enterococcus faecalis is associated with decreased vancomycin susceptibility.. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2024.
• Antimicrobial agents based on metal-ion zeolite materials: a multivariate approach to microbial growth inhibition.. RSC advances, 2025.
• Inactivating pathogenic bacteria in greywater by biosynthesized Cu/Zn nanoparticles from secondary metabolite of Aspergillus iizukae, optimization, mechanism and techno economic analysis.. PloS one, 2019.
• Model membrane approaches to determine the role of calcium for the antimicrobial activity of friulimicin.. International journal of antimicrobial agents, 2011.
• Gram-negative-staining Bacillaceae with thick cell wall and monoderm architecture uncover evolutionary diversity and challenge Gram-based classification.. 2026.
• Multilevel Regulation of Peptidoglycan Dynamics in Bacteria: From Molecular Mechanisms to Applied Perspectives.. 2026.
• Penicillin-Binding Protein-4 (PBP4) of &lt,i&gt,Staphylococcus aureus&lt,/i&gt, and Its Role in β-Lactam Resistance: An Update.. 2026.
• Phage endolysins as alternative antimicrobials: mechanisms, clinical progress, and emerging resistance frameworks.. 2026.
• Surface Characterization and Antimicrobial Capability Evaluation of Medical-Grade Titanium Modified by Facile Immersion in the Solution of Novel Catechol-Terminated Compounds Having Cationic Quaternary Ammonium Functionality with Different Alkyl Chain Lengths.. 2026.
• Detection and identification of pathogens using agents targeting the bacterial cell wall.. 2026.
• Relation of Staining Mechanism of Crystalviolet to Mechanism of the Gram Staining. 1956.
• In situ Plasmon-Enhanced CARS and TPEF for Gram staining identification of non-fluorescent bacteria.. Spectrochimica Acta Part A - Molecular and Biomolecular Spectroscopy, 2021.
• Gram staining and its molcecular mechanism.. International Review of Cytology, 1970.
• A new bacterial staining method involving Gram stain with theoretical considerations of the staining mechanism.. Microbios, 1992.
• [P(CH2OH)4]Cl induced natural shift of methanogenic pathway through disrupting bacterial disulfide bonds and reshaping microbial community structure. Journal of Hazardous Materials, 2025.
• Effects of low-molecular weight alcohols on bacterial viability. Revista Romana De Medicina De Laborator, 2017.
• Teicoplanin: A Review of its Antibacterial Activity, Pharmacokinetic Properties and Therapeutic Potential. Drugs, 1990.

This article is educational and does not replace validated laboratory procedures, institutional biosafety review, manufacturer instructions, or professional interpretation.